Abstract:Background: Dissolution dynamic nuclear polarization is a novel method that increases more than 10,000-fold the 13 C signal-to-noise ratio and emerges as a useful tool for detection of molecules much less prevalent than water in the human body. Hyperpolarized [1- 13 C] pyruvate (HP) permits the noninvasive, nonradioactive study of metabolic flux via pyruvate dehydrogenase, a key enzyme in the complex cardiac adaptation to physical activity, energy sources, and in various disease states. The aim of this study is to define an analysis pipeline of multiparametric, non-steady-state, real-time human cardiac magnetic resonance spectroscopic investigations. Methods: HP was infused intravenously into five human subjects. Dynamic spectroscopic data was acquired for [1- 13 C]- pyruvate, 13 C-alanine, [1- 13 C]-lactate, and 13 C-bicarbonate at two consecutive times for each subject. Imaging data were exported into MATLAB. We employed a first-order kinetic model to fit the signal for the hyperpolarized metabolites assuming bidirectional flow between pyruvate and lactate as well as pyruvate and alanine. A gamma variate input function was used to model the initial pyruvate bolus. We also calculated non-parametric values to describe the signal for each metabolite, specifically area-under-curve (AUC) and time-to-peak (TTP). The repeatability analysis was performed using an ANOVA-based method. Results: Rate constants derived from the kinetic model: kPL 0.016 ± 0.008s -1 , kPA 0.012 ± 0.006s -1 , kPB 0.024±0.0095s -1 are of similar order of magnitude to prior studies. The reverse constant for lactate to pyruvate conversion (kLP) is relatively unchanged across the subjects (0.0099±0.0005), and reverse constant for alanine to pyruvate (kAP) conversion is almost negligible (0.0008 ± 0.0012). The model well describes the metabolites signal over time. Within subject repeatability was higher for TTP (lactate: 0.981 ± 0.018) ) than for rate constants (kPL 0.823 ± 0.153) and AUC (lactate 0.697 ± 0.244) with kPB having the lowest repeatability (0.325 ± 0.424) due to a single outlier. Conclusions: We present a real-time pipeline for analysis and modelling of pyruvate metabolism in the human heart and confirm that it is reproducible within the same subject under same conditions.

Hyperpolarized 13 C Metabolic Imaging of the Human Abdomen with Spatiotemporal Denoising.

Hyperpolarized 13C metabolic imaging of the human abdomen with spatiotemporal denoising

Specialized Computational Methods for Denoising, B1 Correction, and Kinetic Modeling in Hyperpolarized 13 C MR EPSI Studies of Liver Tumors.

Current Methods for Hyperpolarized [1-13C]pyruvate MRI Human Studies

Hyperpolarized 13 C MRI : State of the Art and Future Directions

Current methods for hyperpolarized [1‐13C]pyruvate MRI human studies

Hyperpolarized C MRI: State of the Art and Future Directions.

Hyperpolarized C-13 Mri: State Of The Art And Future Directions

Hyperpolarized [2- 13 C]Pyruvate MR Molecular Imaging with Whole Brain Coverage

Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients

Chemical shift separation with controlled aliasing for hyperpolarized (13) C metabolic imaging

Improved reconstruction stability for chemical shift encoded hyperpolarized 13 C magnetic resonance spectroscopic imaging using k-t spiral acquisitions

A Regional Bolus Tracking and Real-time B$_1$ Calibration Method for Hyperpolarized $^{13}$C MRI

Multi-band echo-planar spectroscopic imaging of hyperpolarized 13 C probes in a compact preclinical PET/MR scanner

Abstract 535: Mathematical Modeling of Hyperpolarized Pyruvate Metabolism in Human Heart

Hyperpolarized Carbon-13 Magnetic Resonance Imaging: Technical Considerations and Clinical Applications

Mutual-Information Based Optimal Experimental Design for Hyperpolarized $^{13}$C-Pyruvate MRI

Enhanced hyperpolarized chemical shift imaging based on a priori segmented information

Integrative Hyperpolarized 13C Metabolic and Standard-of-Care Abdominopelvic Staging/Restaging MRI for Patients with Advanced Solid Tumors

First in‐human evaluation of [1‐13C]pyruvate in D2O for hyperpolarized MRI of the brain: A safety and feasibility study

Hyperpolarized Metabolic MRI—Acquisition, Reconstruction, and Analysis Methods